Catalyst Wire Dossier Catalyst Wire Dossier

GDC-229

· Balmoral Medical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GDC-229, covering 2019-10-14 to 2019-10-14. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis [Phase 3]

See pricing